Market Reacts Favorably to Actinium Pharmaceuticals’ (ATNM) Recent Update
Following a noteworthy regulatory update, Actinium Pharmaceuticals, Inc. (NYSE: ATNM) share are gaining traction on the charts this morning. As of the latest market update, ATNM shares were trading 12.48% higher to $2.79. Regulatory Update on Iomab-B Regarding its Biologics License Application (BLA) submission for Iomab-B, a medication intended for individuals with active relapsed or […]
